"Per eventuali segnalazione scrivere a urp@asst-bgovest.it"

During the past decade, A.O. Treviglio-Caravaggio, P.le Ospedale n1 conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" #1 sponsor was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 8 trials, followed by "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 4 trials as a collaborator, "Azienda Ospedaliero, Universitaria Ospedali Riuniti" with 1 trials as a collaborator, "Cattedra di Endocrinochirurgia, Università di Verona" with 1 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator and "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" are "Breast Cancer" (5 trials), "Cardiovascular Disease" (2 trials), "Metastatic Breast Cancer" (2 trials), "Pancreatic Cancer" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" in a lesser frequency.

Most popular intervention types in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" are "Drug" (18 trials), "Procedure" (3 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "triptorelin" (2 trials) and "Aflibercept, 5fluorouracil, Folinic Acid andIrinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "A.O. Treviglio-Caravaggio, P.le Ospedale n1" are 17 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "A.O. Treviglio-Caravaggio, P.le Ospedale n1". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in A.O. Treviglio-Caravaggio, P.le Ospedale n1, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in A.O. Treviglio-Caravaggio, P.le Ospedale n1, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

A.O. Treviglio-Caravaggio, P.le Ospedale n1 has several departments that took part in Clinical trials: "Ospedali Treviglio-Caravaggio - Cardiologia" - 4 trials, "ASL of Ponte San Pietro - Diabetologic Unit" - 2 trials